Canada Flag

Our Commitment to Research

A Pathway to the Future

At Vertex, we are a science-led organization. Three out of five Vertex employees are dedicated to research and development (R&D) and we invest more of our operating expenses in R&D than pharmaceutical industry averages. We understand the science to help people with serious diseases.

Our scientists have spent the last 20 years doing what was once thought impossible – developing the first medicines that treat the underlying cause of cystic fibrosis (CF).

Vertex by the Numbers
4 CF medicines brought to market for eligible patients in Canada
73% of our 2019 global operating expenses were dedicated to R&D*
$11.8B total USD invested in R&D globally since 2000

*Operating expenses are defined as R&D + Sales General & Administrative. All figures are calculated using generally accepted accounting principles.